PLUS THERAPEUTICS, INC. — Director's Dealing 2023

Jan 4, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLUS THERAPEUTICS, INC. (PSTV)
CIK: 0001095981
Period of Report: 2022-12-30

Reporting Person: Lenk Robert P (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-12-30	Common Stock	S	1500	$0.3147	Disposed	8500	Direct

Footnotes

F1: (1) The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.3141 to $0.3185 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.